CombiMatrix Corporation to Release Second Quarter Financial Results on August 6, 2014
July 30 2014 - 4:05PM
CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will
release its second quarter 2014 financial results on Wednesday,
August 6, 2014. Results will be released after the close of trading
on that day.
A conference call has also been scheduled regarding CombiMatrix
Corporation's second quarter 2014 financial results. The
presentation and Q&A session will start at 1:30 p.m. PDT (4:30
p.m. EDT) on August 6, 2014.
To attend the presentation by phone, dial 1-877-407-0784 for
domestic callers and 1-201-689-8560 for direct-dial or
international callers. The call will be webcast live under the
investor relations section of the CombiMatrix's website, at
www.combimatrix.com.
Date: August 6, 2014
Time: 4:30 PM ET
Listen via Internet: http://investor.combimatrix.com/
Schedule this webcast into MS-Outlook calendar (click open when
prompted):
http://apps.shareholder.com/PNWOutlook/t.aspx?m=65687&k=FA64718F
Toll-free: 1-877-407-0784
International: 1-201-689-8560
A replay of the presentation will be available following the
presentation, either via the CombiMatrix website Investor/Events
section (http://investor.combimatrix.com/events.cfm) or by dialing
1-877-870-5176 for domestic callers or 1-858-384-5517 for
direct-dial international callers. When prompted, enter playback
pin number 13587798.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support to foster the highest
quality in patient care. CombiMatrix specializes in miscarriage
analysis, prenatal testing and pediatric genetics, offering DNA
based testing for the detection of genetic abnormalities beyond
what can be identified through traditional methodologies.
CombiMatrix performs genetic testing utilizing a variety of
advanced cytogenomic techniques, including chromosomal microarray,
standardized and customized fluorescence in situ hybridization
("FISH") and high-resolution karyotyping. CombiMatrix is dedicated
to providing high-level clinical support for healthcare
professionals in order to help them incorporate the results of
complex genetic testing into patient-centered medical decision
making. Additional information about CombiMatrix is available at
www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
Tel (949) 753-0624
Media Contact:
David Schull or Lena Evans
Russo Partners LLC
(212) 845-4271 or (212) 845-4262
david.schull@russopartnersllc.com
lena.evans@russopartnersllc.com
Investor Contact:
Robert Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226
robert.flamm@russopartnersllc.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2024 to Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Jul 2023 to Jul 2024